Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Director of DPUK
Professor John Gallacher comments in the University of Oxford blog

Writing for the University of Oxford blog, Professor Gallacher points to how COVID-19 has exposed the varied models and distributed data on which health policy is developed. He highlights a need for agile and flexible global data access, and the role that data repository platforms such as the Data Portal take in this context.

John writes: “Perhaps the most controversial aspect of COVID has been ‘disease modelling’ – the prediction of what will happen to the disease under different scenarios with governments around the world basing policy on diverse models.

“COVID apart, as emerging research questions become more complex, the need for infrastructure to enable agile and flexible data access becomes acute.”

With health data transforming how researchers tackle pressing public health challenges, platforms for data sharing are democratising how researchers access data and speed disease prevention and treatment.

"The repository approach increases efficiency. By streamlining procedures, it reduces the time required for data access. By bringing scientists to the data, it removes the need for repeated data transfer. It also democratises scientific opportunity through allowing researchers access on the Data Portal to all state-of-the-art software for data analysis at no cost. Whether you live in Manchester or Malawi, if you have a great idea, you can test it on some of the world’s best data (even in lockdown)."

John goes on to describe the some of the key challenges in health research today – management of large datasets, data transfer and the need to compare very different sources of evidence. It is these challenges that the Data Portal is designed to face. In its 18 months of operation, users have made around 600 data access applications and with a number of studies well under way. Although developed to accelerate dementia research, the Data Portal is a generic solution that can be used to study many common diseases.

Read the full article here.

DPUK Data Portal

The Early experience and dementia research programme is currently the largest Data Portal study into dementia.

 

Similar stories

Dementia Ecosystem UK: action through alliance

One in three people born today will develop dementia in their lifetime: it's the biggest health challenge of our generation. With one million people predicted to have dementia by 2025 in the UK, and a current cost of £26bn a year to the UK economy, there is huge financial and societal impact, yet we’re still without treatment.

Cohorts invited to join dementia trials register

DPUK has launched Great Minds, an innovative new register of volunteers for clinical trials who bring rich data from their previous health studies to help clear the deadlock in development of treatments for dementia.

Datathon for dementia

Data scientists from many different backgrounds combined their expertise to take on dementia in an unusual format for disease research: a three-day datathon. The intensive research event saw teams come together to work on data that is now available in the DPUK Data Portal.

DPUK approach attracts interest from beyond dementia sector

Thanks to leaps forward in computing power, DPUK is able to harness highly advanced technical solutions to maintain data security and non-identifiability of millions of existing health records in the Data Portal. It’s a model that is globally unique for dementia research and one that’s increasingly attracting attention from other sectors.

Why volunteer health data will accelerate the development of treatments for dementia

Thanks to the generosity of two million health studies volunteers, there is new hope for accelerating the discovery of treatments for dementia. Their combined data – lifestyle, genes, memory tests, and brain scans – are helping researchers identify changes over time which will reveal how dementia starts in healthy brains.

New partner announcement: Cambridge Cognition

Dementias Platform UK continues to expand as Cambridge Cognition, a global leader in cognitive assessment for clinical trials, upgrades its current position as associate partner to become full partner.